Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0805 | 0.196 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.234 | 0.2092 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0016 | 0.0313 | 0.5 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0016 | 0.0313 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0805 | 0.196 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0805 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0805 | 0.066 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0047 | 0.254 | 0.2985 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0016 | 0.0313 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.254 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0024 | 0.09 | 0.2634 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.254 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.234 | 0.9101 |
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.254 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0107 | 0.6906 | 0.8837 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.09 | 0.2634 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0107 | 0.6906 | 0.8837 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0119 | 0.7773 | 1 |
Treponema pallidum | NADH oxidase | 0.0016 | 0.0313 | 0.5 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0017 | 0.0383 | 0.031 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0805 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0805 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0017 | 0.0383 | 0.0093 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0805 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0024 | 0.09 | 0.2634 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.254 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.254 | 1 |
Brugia malayi | hypothetical protein | 0.0024 | 0.09 | 0.3543 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0274 | 0.1077 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.254 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0805 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0805 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0805 | 0.221 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0.0383 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0107 | 0.6906 | 0.8755 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0805 | 0.066 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0119 | 0.7773 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.254 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0107 | 0.6906 | 0.8837 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.234 | 0.2092 |
Mycobacterium tuberculosis | Probable reductase | 0.0107 | 0.6906 | 0.8837 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0314 | 0.0001 |
Leishmania major | trypanothione reductase | 0.0047 | 0.254 | 1 |
Onchocerca volvulus | 0.0023 | 0.0805 | 0.5 | |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.254 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.254 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.234 | 0.9101 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0016 | 0.0313 | 0.1234 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.254 | 1 |
Brugia malayi | glutathione reductase | 0.0047 | 0.254 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0023 | 0.0805 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0805 | 0.221 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0805 | 0.3171 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.254 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0314 | 0.0001 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.09 | 0.2634 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.234 | 0.9101 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0805 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.09 | 0.2634 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0805 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.254 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0313 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0119 | 0.7773 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0044 | 0.234 | 0.9212 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0314 | 0.0001 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0024 | 0.09 | 0.2634 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0805 | 0.196 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0044 | 0.234 | 0.9072 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0024 | 0.09 | 0.2634 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0119 | 0.7773 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0107 | 0.6906 | 0.8837 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0805 | 0.3171 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.234 | 0.9101 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.09 | 0.2398 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0023 | 0.0805 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0024 | 0.09 | 0.2634 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0017 | 0.0383 | 0.031 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0313 | 0.5 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0314 | 0.0001 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0017 | 0.0383 | 0.1405 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0023 | 0.0805 | 0.221 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0805 | 0.3171 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0805 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.234 | 0.2092 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0107 | 0.6906 | 0.8837 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | > 100 uM | Huh7 cytotoxicity for Pf inhibitors | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 0.508 uM | W2 Pf proliferation inhibition | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 1.182 uM | PF proliferation inhibition 3D7 | Novartis-GNF Malaria Box. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.